Donor and recipient graft survival. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy24

Transplants Antilymphocyte Serum Kidney T-Lymphocytes Allografts Spleen Cells, Cultured Portal Vein Saphenous Vein Endothelium, Corneal Liver CD4-Positive T-Lymphocytes Hepatic Artery Cornea Veins T-Lymphocytes, Regulatory CD8-Positive T-Lymphocytes Lymphocytes Ear Auricle Islets of Langerhans T-Lymphocyte Subsets B-Lymphocytes Femoral Artery Lymph Nodes

Organisms17

Mice, Inbred C57BL Rats, Inbred Lew Mice, Inbred BALB C Rats, Inbred WF Transplantation Chimera Mice, Knockout Mice, Inbred Strains Mice, Inbred C3H Mice, Transgenic Mice, Inbred CBA Rats, Inbred BN Cytomegalovirus Mice, SCID Mice, Inbred NOD Radiation Chimera Rats, Inbred ACI Swine

Diseases41

Cadaver Graft Occlusion, Vascular Postoperative Complications Delayed Graft Function Brain Death Liver Failure Primary Graft Dysfunction Death Kidney Failure, Chronic Graft vs Host Disease Recurrence Cytomegalovirus Infections Acute Disease Blood Group Incompatibility Corneal Neovascularization Liver Diseases Hepatitis C Kidney Diseases Disease Models, Animal Corneal Edema Biliary Tract Diseases Diabetes Mellitus, Type 1 Corneal Endothelial Cell Loss Corneal Diseases Chronic Disease Renal Insufficiency Ischemia Infection Thrombosis Disease Progression Biliary Atresia Lymphoproliferative Disorders Fuchs' Endothelial Dystrophy Reperfusion Injury Constriction, Pathologic Neoplasm Recurrence, Local Liver Cirrhosis Hematologic Neoplasms Lung Neoplasms Proteinuria Keratoconus

Chemicals and Drugs40

Immunosuppressive Agents Tacrolimus Cyclosporine Mycophenolic Acid Isoantibodies Antilymphocyte Serum HLA Antigens Azathioprine Organ Preservation Solutions Isoantigens Creatinine Polytetrafluoroethylene Antibodies, Monoclonal Complement C4b Sirolimus Immunoconjugates Raffinose ABO Blood-Group System Prednisone Cyclosporins Calcineurin Polyethylene Terephthalates CD40 Ligand Procaine Steroids Biological Markers Antibodies Ganciclovir Cytokines Methylprednisolone Antigens, CD Histocompatibility Antigens Interferon-gamma RNA, Messenger Propylene Glycols Antiviral Agents Adrenal Cortex Hormones Allopurinol HLA-B Antigens Antineoplastic Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment102

Kidney Transplantation Survival Rate Liver Transplantation Transplantation, Homologous Treatment Outcome Heart Transplantation Retrospective Studies Pancreas Transplantation Corneal Transplantation Histocompatibility Testing Survival Analysis Immunosuppression Keratoplasty, Penetrating Skin Transplantation Follow-Up Studies Cold Ischemia Disease-Free Survival Islets of Langerhans Transplantation Organ Preservation Transplantation Kaplan-Meier Estimate Transplantation, Heterotopic Organ Transplantation Graft Enhancement, Immunologic Reoperation Risk Factors Proportional Hazards Models Bone Marrow Transplantation Tissue and Organ Harvesting Lung Transplantation Donor Selection Blood Vessel Prosthesis Transplantation, Isogeneic Prospective Studies Multivariate Analysis Biopsy Anastomosis, Surgical Cohort Studies Prognosis Incidence Fetal Tissue Transplantation Drug Therapy, Combination Risk Assessment Blood Transfusion Hematopoietic Stem Cell Transplantation Transplantation, Heterologous Actuarial Analysis Lymphocyte Culture Test, Mixed Postoperative Period Registries Patient Selection Immunohistochemistry Disease Models, Animal Blood Vessel Prosthesis Implantation Nephrectomy Descemet Stripping Endothelial Keratoplasty Lymphocyte Transfusion Models, Animal Kidney Function Tests Brain Tissue Transplantation Cell Transplantation Predictive Value of Tests Renal Dialysis Treatment Failure Transplantation Conditioning Blood Grouping and Crossmatching Adoptive Transfer Transplantation, Autologous Warm Ischemia Glomerular Filtration Rate Plasmapheresis Neoplasm Staging Probability Cryopreservation Postoperative Care Lymphocyte Depletion Chi-Square Distribution Combined Modality Therapy Coronary Artery Bypass Hepatectomy Antineoplastic Combined Chemotherapy Protocols Stem Cell Transplantation Drug Administration Schedule Lymphocyte Activation Preoperative Care Polymerase Chain Reaction Severity of Illness Index Cause of Death Liver Function Tests Administration, Ophthalmic Reverse Transcriptase Polymerase Chain Reaction Whole-Body Irradiation Arteriovenous Shunt, Surgical Flow Cytometry Enzyme-Linked Immunosorbent Assay Life Tables Prosthesis Design Cell Count Thymectomy Reconstructive Surgical Procedures Oocyte Donation Risk

Phenomena and Processes26

Graft Survival Graft Rejection Cell Survival Time Factors Transplantation Tolerance Transplantation Immunology Histocompatibility Immune Tolerance Vascular Patency Apoptosis Glomerular Filtration Rate Probability Chi-Square Distribution Graft vs Host Reaction Cell Proliferation Signal Transduction Lymphocyte Activation Cell Differentiation Radiation Chimera Host vs Graft Reaction Conjugation, Genetic Cell Count Genotype Cell Movement Dose-Response Relationship, Drug Risk

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Technology, Industry, Agriculture2

Polytetrafluoroethylene Polyethylene Terephthalates

Information Science6

Survival Rate Incidence Registries Databases as Topic Cause of Death Life Tables

Named Groups4

Tissue Donors Living Donors Blood Donors Infant, Newborn

Health Care32

Survival Rate Treatment Outcome Retrospective Studies Tissue and Organ Procurement Survival Analysis Follow-Up Studies Disease-Free Survival Kaplan-Meier Estimate Risk Factors Proportional Hazards Models Donor Selection Prospective Studies Multivariate Analysis Age Factors Waiting Lists Cohort Studies Incidence Risk Assessment Actuarial Analysis Postoperative Period Registries Patient Selection Predictive Value of Tests Treatment Failure Probability Postoperative Care Chi-Square Distribution Preoperative Care Severity of Illness Index Cause of Death Life Tables Risk

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Graft Survival Kidney Transplantation Tissue Donors Graft Rejection Living Donors Survival Rate Liver Transplantation Transplantation, Homologous Cadaver Cell Survival Treatment Outcome Heart Transplantation Immunosuppressive Agents Time Factors Retrospective Studies Pancreas Transplantation Tissue and Organ Procurement Corneal Transplantation Histocompatibility Testing Blood Donors Survival Analysis Immunosuppression Tacrolimus Graft Occlusion, Vascular Keratoplasty, Penetrating Cyclosporine Skin Transplantation Postoperative Complications Delayed Graft Function Follow-Up Studies Transplants Cold Ischemia Disease-Free Survival Mycophenolic Acid Islets of Langerhans Transplantation Organ Preservation Transplantation Brain Death Transplantation Tolerance Transplantation Immunology Kaplan-Meier Estimate Liver Failure Transplantation, Heterotopic Survival Organ Transplantation Isoantibodies Graft Enhancement, Immunologic Reoperation Antilymphocyte Serum Mice, Inbred C57BL Risk Factors Primary Graft Dysfunction HLA Antigens Proportional Hazards Models Bone Marrow Transplantation Death Kidney Failure, Chronic Histocompatibility Rats, Inbred Lew Azathioprine Tissue and Organ Harvesting Mice, Inbred BALB C Lung Transplantation Donor Selection Blood Vessel Prosthesis Graft vs Host Disease Kidney Transplantation, Isogeneic Recurrence Organ Preservation Solutions Prospective Studies Multivariate Analysis Biopsy Isoantigens Creatinine T-Lymphocytes Polytetrafluoroethylene Age Factors Waiting Lists Anastomosis, Surgical Cohort Studies Prognosis Cytomegalovirus Infections Antibodies, Monoclonal Incidence Acute Disease Fetal Tissue Transplantation Allografts Drug Therapy, Combination Risk Assessment Spleen Blood Group Incompatibility Complement C4b Blood Transfusion Corneal Neovascularization Hematopoietic Stem Cell Transplantation Sirolimus Immunoconjugates Transplantation, Heterologous Immune Tolerance

No FAQ available that match "donor and recipient graft survival"